These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2018353)

  • 1. Expression of oncogenes in human breast cancer specimens.
    Köster A; Landgraf S; Leipold A; Sachse R; Gebhart E; Tulusan AH; Rónay G; Schmidt C; Dingermann T
    Anticancer Res; 1991; 11(1):193-201. PubMed ID: 2018353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of c-erbB-2 oncoprotein expression in breast tissue by multiparameter flow cytometry.
    Li BD; Bauer KD; Carney WP; Duda RB
    J Surg Res; 1993 Mar; 54(3):179-88. PubMed ID: 7682635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
    Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G
    Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
    Press MF; Pike MC; Chazin VR; Hung G; Udove JA; Markowicz M; Danyluk J; Godolphin W; Sliwkowski M; Akita R
    Cancer Res; 1993 Oct; 53(20):4960-70. PubMed ID: 8104689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased erbB-2 gene copies and expression in multiple stages of breast cancer.
    Iglehart JD; Kraus MH; Langton BC; Huper G; Kerns BJ; Marks JR
    Cancer Res; 1990 Oct; 50(20):6701-7. PubMed ID: 2208136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ras, c-myc and c-erbB-2 oncoproteins in human breast cancer.
    Spandidos DA; Yiagnisis M; Papadimitriou K; Field JK
    Anticancer Res; 1989; 9(5):1385-93. PubMed ID: 2574023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading.
    Berger MS; Locher GW; Saurer S; Gullick WJ; Waterfield MD; Groner B; Hynes NE
    Cancer Res; 1988 Mar; 48(5):1238-43. PubMed ID: 2893663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
    Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic and predictive relevance of c-erbB-2 and ras expression in node positive and negative breast cancer.
    Giai M; Roagna R; Ponzone R; De Bortoli M; Dati C; Sismondi P
    Anticancer Res; 1994; 14(3B):1441-50. PubMed ID: 7915096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumorigenicity assay of the human mammary carcinoma cell line MCF-7.
    Marics I; Adelaide J; Rosnet O; Planche J; Pirisi V; Birnbaum D
    Anticancer Res; 1989; 9(6):1627-31. PubMed ID: 2560622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological correlation between HER-2/neu and proliferative activity in human breast cancer.
    Tommasi S; Paradiso A; Mangia A; Barletta A; Simone G; Slamon DJ; De Lena M
    Anticancer Res; 1991; 11(4):1395-400. PubMed ID: 1684096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current molecular prognostic factors in breast carcinoma].
    Fey MF; Andres AC; Castiglione-Gertsch M
    Schweiz Med Wochenschr; 1992 Oct; 122(40):1471-8. PubMed ID: 1357743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
    Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-level expression of the ribosomal protein L19 in human breast tumors that overexpress erbB-2.
    Henry JL; Coggin DL; King CR
    Cancer Res; 1993 Mar; 53(6):1403-8. PubMed ID: 8095182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of c-erbB-2 amplification by immunohistochemistry in paraffin-embedded breast cancer.
    Kerns BJ; Jordan PA; Huper G; Marks JR; Iglehart JD; Layfied LJ
    Mod Pathol; 1993 Nov; 6(6):673-8. PubMed ID: 7905629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined erbB gene overexpression and decreased H-ras gene expression in human gliomas.
    Patt S; Cervós-Navarro J
    Acta Histochem Suppl; 1992; 42():131-8. PubMed ID: 1584958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amplification of HER-2(erbB-2/neu) oncogene as the most significant prognostic factor in a group of Russian breast cancer patients.
    Imyanitov EN; Chernitsa OI; Serova OM; Nikoforova IF; Pluzhnikova GF; Knyazev PG
    Neoplasma; 1993; 40(1):35-9. PubMed ID: 7688867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific expression of cellular oncogenes c-myc and c-myb in T-cell lines established from three types of bovine lymphosarcomas.
    Ishiguro N; Matsui T; Shinagawa M
    Am J Vet Res; 1993 Dec; 54(12):2010-4. PubMed ID: 8116930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneous expression of erbB-2 messenger RNA in human breast cancer.
    King CR; Swain SM; Porter L; Steinberg SM; Lippman ME; Gelmann EP
    Cancer Res; 1989 Aug; 49(15):4185-91. PubMed ID: 2568168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
    Volm M; Mattern J
    Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.